BioCentury | Jun 18, 2012
Emerging Company Profile

Armour: Relaxin in CRPC

Armour Therapeutics Inc. 's relaxin receptor antagonists may provide a complementary hormonal therapy that can be given either with or after anti-androgen therapy in prostate cancer patients. Targeting a secondary pathway alongside an androgen pathway...
Items per page:
1 - 1 of 1
BioCentury | Jun 18, 2012
Emerging Company Profile

Armour: Relaxin in CRPC

Armour Therapeutics Inc. 's relaxin receptor antagonists may provide a complementary hormonal therapy that can be given either with or after anti-androgen therapy in prostate cancer patients. Targeting a secondary pathway alongside an androgen pathway...
Items per page:
1 - 1 of 1